{
  "compound": "CBD-rich cannabis extract",
  "condition": "IBD_CROHNS",
  "effect_size": "Small for remission (d = 0.08)",
  "study_type": "RCT",
  "source": "NORML:IBD_RCT_004",
  "participants": "60 patients with active ulcerative colitis",
  "year": 2018,
  "notes": "Cannabis for Ulcerative Colitis: Randomized Controlled Trial",
  "confidence": "medium",
  "abstract": "Cannabis: 28% remission vs Placebo: 26%; Not significant for remission but 59% had clinical response"
}